ArticleJournal of medicinal chemistry2012

Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.

Brian R Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.